Follow
Maria Majellaro
Maria Majellaro
Celtarys Research
Verified email at usc.es
Title
Cited by
Cited by
Year
New azepino [4, 3-b] indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity
M De Candia, G Zaetta, N Denora, D Tricarico, M Majellaro, S Cellamare, ...
European journal of medicinal chemistry 125, 288-298, 2017
492017
Structure-based design of potent and selective ligands at the four adenosine receptors
W Jespers, A Oliveira, R Prieto-Díaz, M Majellaro, J Åqvist, E Sotelo, ...
Molecules 22 (11), 1945, 2017
362017
X‐Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A2A Adenosine Receptor Antagonists
W Jespers, G Verdon, J Azuaje, M Majellaro, H Keränen, X García‐Mera, ...
Angewandte Chemie International Edition 59 (38), 16536-16543, 2020
242020
3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and …
M Majellaro, W Jespers, A Crespo, MJ Núñez, S Novio, J Azuaje, ...
Journal of Medicinal Chemistry 64 (1), 458-480, 2020
232020
Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists
A Mallo-Abreu, R Prieto-Díaz, W Jespers, J Azuaje, M Majellaro, ...
Journal of Medicinal Chemistry 63 (14), 7721-7739, 2020
222020
Effect of Nitrogen Atom Substitution in A3 Adenosine Receptor Binding: N-(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective Antagonists
J Azuaje, W Jespers, V Yaziji, A Mallo, M Majellaro, O Caamano, MI Loza, ...
Journal of Medicinal Chemistry 60 (17), 7502-7511, 2017
182017
Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition
A Mallo-Abreu, M Majellaro, W Jespers, J Azuaje, O Caamano, ...
Journal of Medicinal Chemistry 62 (20), 9315-9330, 2019
172019
Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
I Raïch, R Rivas-Santisteban, A Lillo, J Lillo, I Reyes-Resina, X Nadal, ...
Pharmacological Research 174, 105970, 2021
162021
Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition
X Wang, W Jespers, R Prieto-Díaz, M Majellaro, AP IJzerman, ...
Scientific Reports 11 (1), 14171, 2021
122021
Catalytic performance of a metal-free graphene oxide-Al2O3 composite assembled by 3D printing
J Azuaje, A Rama, A Mallo-Abreu, MG Boado, M Majellaro, CR Tubío, ...
Journal of the European Ceramic Society 41 (2), 1399-1406, 2021
122021
Novel antiproliferative biphenyl nicotinamide: NMR metabolomic study of its effect on the MCF-7 cell in comparison with cisplatin and vinblastine
L Del Coco, M Majellaro, A Boccarelli, S Cellamare, CD Altomare, ...
Molecules 25 (15), 3502, 2020
112020
A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
AHM Tay, R Prieto-Díaz, S Neo, L Tong, X Chen, V Carannante, B Önfelt, ...
Journal for Immunotherapy of Cancer 10 (5), 2022
102022
Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists
R Prieto-Díaz, M González-Gómez, H Fojo-Carballo, J Azuaje, ...
Journal of Medicinal Chemistry 66 (1), 890-912, 2022
92022
Exploring the influence of the substituent at position 4 in a series of 3,4-dihydropyrimidin-2(1H)-one A2B adenosine receptor antagonists
A Crespo, A El Maatougui, J Azuaje, L Escalante, M Majellaro, MI Loza, ...
Chemistry of Heterocyclic Compounds 53, 316-321, 2017
82017
Investigating structural requirements for the antiproliferative activity of biphenyl nicotinamides
M Majellaro, A Stefanachi, P Tardia, C Vicenti, A Boccarelli, A Pannunzio, ...
ChemMedChem 12 (16), 1380-1389, 2017
72017
Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists
D Miranda-Pastoriza, R Bernárdez, J Azuaje, R Prieto-Díaz, M Majellaro, ...
ACS Medicinal Chemistry Letters 13 (2), 243-249, 2022
52022
Potent and Subtype-Selective Dopamine D2 Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
A Mallo-Abreu, I Reyes-Resina, J Azuaje, R Franco, A García-Rey, ...
Journal of Medicinal Chemistry 64 (12), 8710-8726, 2021
42021
Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands
J Barbazán, M Majellaro, AL Martínez, JM Brea, E Sotelo, M Abal
Biomedicine & Pharmacotherapy 153, 113408, 2022
32022
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists
C Val, C Rodríguez-García, R Prieto-Díaz, A Crespo, J Azuaje, ...
Journal of Medicinal Chemistry 65 (3), 2091-2106, 2022
32022
Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary …
I Bolognino, A Carrieri, R Purgatorio, M Catto, R Caliandro, B Carrozzini, ...
Separations 9 (1), 7, 2021
32021
The system can't perform the operation now. Try again later.
Articles 1–20